Works Cited

Safe Handling of Hazardous Medications

Course #91380 - $15-

  • Back to Course Home
  • Participation Instructions
    • Review the course material online or in print.
    • Complete the course evaluation.
    • Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.

1. United States Pharmacopeia. <800> Hazardous Drugs: Handling in Healthcare Setting. In: United States Pharmacopeia and National Formulary (USP 43-NF 38).

2. United States Pharmacopeia. USP <800> FAQs. Available at https://go.usp.org/General-Chapter-800-FAQ. Last accessed February 9, 2023.

3. National Institute for Occupational Safety and Health. Hazardous Drug Exposures in Healthcare. Available at https://www.cdc.gov/niosh/topics/hazdrug/riskmanagement.html. Last accessed February 9, 2023.

4. National Institute for Occupational Safety and Health. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Setting, 2016. Available at https://www.cdc.gov/niosh/docs/2016-161. Last accessed February 9, 2023.

5. National Institute for Occupational Safety. NIOSH List of Hazardous Drugs in Healthcare Settings, 2020. Available at https://www.cdc. gov/niosh/docket/review/docket233c/pdfs/DRAFT-NIOSH-Hazardous-Drugs-List-2020.pdf. Last accessed February 9, 2023.

6. United States Pharmacopeia. Revision Bulletin: <800> Hazardous Drugs – Handling in Healthcare Settings. Available at https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/gc-800-rb-notice-20200626.pdf. Last accessed February 9, 2023.

7. Power LA, Coyne JW. ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm. 2018;75:1996-2031.

8. American Society of Hospital Pharmacists. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies.Am J Hosp Pharm. 1994;51:1441-1448.

9. U.S. Food and Drug Administration. FDA Warns Against Using Treanda Injection (Solution) with Closed System Transfer Devices, Adapters, and Syringes Containing Polycarbonate or Acrylonitrile-butadiene-styrene; Provides List of Compatible Devices. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-against-using-treanda-injection-solution-closed-system-transfer-devices-adapters-and. Last accessed February 9, 2023.

10. Teva Pharmaceuticals USA, Inc. Prescribing Information: Bendeka (Bendamustine Hydrochloride) Injection, for Intravenous Use. Available at https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/208194s000lbl.pdf. Last accessed February 9, 2023.

11. United States Pharmacopeia. <797> Pharmaceutical Compounding – Sterile Preparations.  In:  United States Pharmacopeia and National Formulary (USP 42-NF 37).

12. Occupational Safety and Health Administration. Administering Hazardous Drugs. Available at https://www.osha.gov/etools/hospitals/patient-care-unit/administering-hazardous-drugs. Last accessed February 9, 2023.

  • Back to Course Home
  • Participation Instructions
    • Review the course material online or in print.
    • Complete the course evaluation.
    • Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.